On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical ...
DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...
Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene therapy to ...
The pharmaceutical distributor has launched InspiroGene, a business unit offering logistics and other support for ...
They're very, very rare now, especially in women who are getting breast-conserving therapy alone. The patients who may have ... What I tell them is that radiation disrupts the DNA in the good cells ...
An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford ...
An expert explained how a patient’s own T cells can be extracted, manufactured and infused back into the body as a treatment ...
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
Cyrus M. Khan, MD, discussed recent advancements in CLL treatment, particularly the shift to nonchemotherapy options and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback